Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Free Report) in a report issued on Friday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Separately, Roth Mkm restated a buy rating on shares of Tenax Therapeutics in a research report on Tuesday, February 20th. Get Our Latest Stock Analysis […]

Leave a Reply

Your email address will not be published.

Previous post Alimentation Couche-Tard (TSE:ATD) PT Raised to C$84.00 at National Bankshares
Next post National Western Life Group (NASDAQ:NWLI) Research Coverage Started at StockNews.com